1. Home
  2. SGMT vs BCBP Comparison

SGMT vs BCBP Comparison

Compare SGMT & BCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • BCBP
  • Stock Information
  • Founded
  • SGMT 2006
  • BCBP 2000
  • Country
  • SGMT United States
  • BCBP United States
  • Employees
  • SGMT N/A
  • BCBP N/A
  • Industry
  • SGMT
  • BCBP Savings Institutions
  • Sector
  • SGMT
  • BCBP Finance
  • Exchange
  • SGMT Nasdaq
  • BCBP Nasdaq
  • Market Cap
  • SGMT 165.4M
  • BCBP 181.7M
  • IPO Year
  • SGMT 2023
  • BCBP N/A
  • Fundamental
  • Price
  • SGMT $4.12
  • BCBP $9.96
  • Analyst Decision
  • SGMT Strong Buy
  • BCBP Hold
  • Analyst Count
  • SGMT 7
  • BCBP 2
  • Target Price
  • SGMT $25.71
  • BCBP $13.38
  • AVG Volume (30 Days)
  • SGMT 864.8K
  • BCBP 60.8K
  • Earning Date
  • SGMT 03-24-2025
  • BCBP 01-28-2025
  • Dividend Yield
  • SGMT N/A
  • BCBP 6.32%
  • EPS Growth
  • SGMT N/A
  • BCBP N/A
  • EPS
  • SGMT N/A
  • BCBP 0.99
  • Revenue
  • SGMT N/A
  • BCBP $83,391,000.00
  • Revenue This Year
  • SGMT N/A
  • BCBP N/A
  • Revenue Next Year
  • SGMT N/A
  • BCBP $9.82
  • P/E Ratio
  • SGMT N/A
  • BCBP $10.25
  • Revenue Growth
  • SGMT N/A
  • BCBP N/A
  • 52 Week Low
  • SGMT $2.39
  • BCBP $9.19
  • 52 Week High
  • SGMT $7.64
  • BCBP $14.04
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 43.11
  • BCBP 31.19
  • Support Level
  • SGMT $3.96
  • BCBP $10.41
  • Resistance Level
  • SGMT $4.83
  • BCBP $10.46
  • Average True Range (ATR)
  • SGMT 0.38
  • BCBP 0.24
  • MACD
  • SGMT -0.04
  • BCBP -0.04
  • Stochastic Oscillator
  • SGMT 13.39
  • BCBP 0.89

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection, and automated teller services.

Share on Social Networks: